BR0009746A - Molécula de veìculo, composição imunogênica, polipeptìdeo, método para tratar um indivìduo, e, plasmìdeos pebl1-pv e pviii - Google Patents
Molécula de veìculo, composição imunogênica, polipeptìdeo, método para tratar um indivìduo, e, plasmìdeos pebl1-pv e pviiiInfo
- Publication number
- BR0009746A BR0009746A BR0009746-2A BR0009746A BR0009746A BR 0009746 A BR0009746 A BR 0009746A BR 0009746 A BR0009746 A BR 0009746A BR 0009746 A BR0009746 A BR 0009746A
- Authority
- BR
- Brazil
- Prior art keywords
- nucleic acids
- lissavirus
- chimeric
- pebl1
- pviii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
"MOLéCULA DE VEìCULO, COMPOSIçãO IMUNOGêNICA, POLIPEPTìDEO, MéTODO PARA TRATAR UM INDIVìDUO, E, PLASMìDEOS pEBL1-PV E PVIII". A presente invenção provê ácidos nucleicos quiméricos, preferivelmente contidos em um vetor de expressão, que codificam polipeptídeos imunogênicos quiméricos. Os ácidos nucleicos codificam pelo menos um sítio III de uma proteína de lissavírus, que foi constatada como aperfeiçoando a imunogenicidade de epítopos de lissavírus para a proteção contra a raiva. As proteínas e ácidos nucleicos quiméricos podem também conter determinantes antigênicos para outros epítopos que aqueles de lissavírus. Deste modo, a invenção provê polipeptídeos e ácidos nucleicos quiméricos, que eliciam uma forte resposta imune para antígenos múltiplos. O uso dos métodos da presente invenção permite a vacinação de DNA sem a necessidade de suprir antígenos múltiplos em moléculas de DNA separadas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12950199P | 1999-04-15 | 1999-04-15 | |
| PCT/IB2000/000564 WO2000063242A1 (en) | 1999-04-15 | 2000-04-17 | Chimeric lyssavirus nucleic acids and polypeptides |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| BR0009746A true BR0009746A (pt) | 2002-01-22 |
| BRPI0009746B1 BRPI0009746B1 (pt) | 2016-08-30 |
| BRPI0009746B8 BRPI0009746B8 (pt) | 2016-10-04 |
| BRPI0009746C1 BRPI0009746C1 (pt) | 2021-05-25 |
Family
ID=22440282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0009746A BRPI0009746C1 (pt) | 1999-04-15 | 2000-04-17 | molécula de veículo contendo plasmídeo pg-pviii compreendendo uma seqúência que codifica uma parte de uma glicoproteína de lissavírus contendo pelo menos o sítio iii da glicoproteína de lissavírus mas não contendo o sítio ii, e, composição imunogênica |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1171454B1 (pt) |
| AR (2) | AR023505A1 (pt) |
| AT (1) | ATE328003T1 (pt) |
| BR (1) | BRPI0009746C1 (pt) |
| CA (1) | CA2370278C (pt) |
| CY (1) | CY1105176T1 (pt) |
| DE (1) | DE60028365T2 (pt) |
| DK (2) | DK1721982T3 (pt) |
| ES (2) | ES2267510T3 (pt) |
| MX (1) | MXPA01010481A (pt) |
| PT (2) | PT1721982E (pt) |
| WO (1) | WO2000063242A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006016380A2 (en) * | 2004-08-13 | 2006-02-16 | Council Of Scientific And Industrial Research | A chimeric g protein based rabies vaccine |
| TW200907058A (en) | 2007-05-30 | 2009-02-16 | Wyeth Corp | Raccoon poxvirus expressing rabies glycoproteins |
| CN109111507B (zh) * | 2017-08-22 | 2021-12-24 | 浙江派迪畅科技发展有限公司 | 病毒重组糖蛋白及其真核细胞高效表达方法与应用 |
| CN111040998B (zh) * | 2019-12-25 | 2023-05-05 | 广东省农业科学院动物卫生研究所 | 一种稳定表达狂犬病毒糖蛋白细胞株的构建及其应用 |
-
2000
- 2000-04-14 AR ARP000101749A patent/AR023505A1/es active IP Right Grant
- 2000-04-17 BR BRPI0009746A patent/BRPI0009746C1/pt not_active IP Right Cessation
- 2000-04-17 EP EP00917245A patent/EP1171454B1/en not_active Expired - Lifetime
- 2000-04-17 ES ES00917245T patent/ES2267510T3/es not_active Expired - Lifetime
- 2000-04-17 MX MXPA01010481A patent/MXPA01010481A/es active IP Right Grant
- 2000-04-17 PT PT61125829T patent/PT1721982E/pt unknown
- 2000-04-17 AT AT00917245T patent/ATE328003T1/de active
- 2000-04-17 DK DK06112582.9T patent/DK1721982T3/da active
- 2000-04-17 DK DK00917245T patent/DK1171454T3/da active
- 2000-04-17 DE DE60028365T patent/DE60028365T2/de not_active Expired - Lifetime
- 2000-04-17 WO PCT/IB2000/000564 patent/WO2000063242A1/en active IP Right Grant
- 2000-04-17 CA CA2370278A patent/CA2370278C/en not_active Expired - Lifetime
- 2000-04-17 PT PT00917245T patent/PT1171454E/pt unknown
- 2000-04-17 ES ES06112582T patent/ES2410593T3/es not_active Expired - Lifetime
-
2006
- 2006-08-29 CY CY20061101211T patent/CY1105176T1/el unknown
-
2008
- 2008-04-01 AR ARP080101360A patent/AR065908A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000063242A1 (en) | 2000-10-26 |
| BRPI0009746B1 (pt) | 2016-08-30 |
| PT1171454E (pt) | 2006-09-29 |
| CA2370278A1 (en) | 2000-10-26 |
| ES2410593T3 (es) | 2013-07-02 |
| ATE328003T1 (de) | 2006-06-15 |
| CA2370278C (en) | 2011-08-09 |
| WO2000063242A8 (en) | 2001-03-22 |
| DK1171454T3 (da) | 2006-08-21 |
| EP1171454B1 (en) | 2006-05-31 |
| AR065908A2 (es) | 2009-07-08 |
| DE60028365D1 (de) | 2006-07-06 |
| DE60028365T2 (de) | 2007-04-12 |
| EP1171454A1 (en) | 2002-01-16 |
| ES2267510T3 (es) | 2007-03-16 |
| PT1721982E (pt) | 2013-06-06 |
| CY1105176T1 (el) | 2010-03-03 |
| BRPI0009746B8 (pt) | 2016-10-04 |
| DK1721982T3 (da) | 2013-04-29 |
| BRPI0009746C1 (pt) | 2021-05-25 |
| AR023505A1 (es) | 2002-09-04 |
| MXPA01010481A (es) | 2002-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000020027A3 (en) | Methods for therapeutic vaccination | |
| BR0013542A (pt) | Moléculas b7-4 e usos para as mesmas | |
| CO5070644A1 (es) | Vacunas que comprenden proteinas e6 de hpv y/o e7 de hpv junto con un oligonucleotido cpg como adyudante | |
| SG153874A1 (en) | Neutralizing epitope-based growth enhancing vaccine | |
| FI102382B1 (fi) | Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten | |
| EP1847549A3 (en) | Papillomavirus polyprotein constructs | |
| BR0007840A (pt) | Proteìnas de fusão her-2/neu | |
| EP0855918A4 (en) | INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF | |
| BR9809445A (pt) | Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico. | |
| BR0015137A (pt) | Peptìdeos antigênicos de neisseria | |
| BR0010155A (pt) | Proteìnas isolada, e quimérica, composição, molécula de ácido nucleico, plasmìdeo, vacina recombinante ou vacina atenuada, composição de vacina recombinante ou composição de vacina atenuada, composição farmacêutica, métodos de imunizar um indivìduo contra um imunógeno, proteìna não-cd80 isolada, molécula de ácido nucleico, e, método de imunossuprimir um indivìduo | |
| KR970705408A (ko) | 헤모필루스 부착 및 침투 단백질(haemophilus adherence and penetration proteins) | |
| WO2002074920A3 (en) | A replication-defective alphavirus vaccine linking antigen with an immunogenicity-potentiating polypeptide and a method of delivery the same | |
| HK51597A (en) | Vaccines for human respiratory virus | |
| GB0118532D0 (en) | Materials and methods relating to improved vaccination strategies | |
| BR0009746A (pt) | Molécula de veìculo, composição imunogênica, polipeptìdeo, método para tratar um indivìduo, e, plasmìdeos pebl1-pv e pviii | |
| DE69836520D1 (de) | Clostridium perfringens Impfstoff | |
| FI902569A0 (fi) | Producering av till gonorre anslutande pi-proteiner och vaccin. | |
| WO2002020038A3 (en) | Method for down-regulating ige | |
| BR9709993A (pt) | Vacina preparação de vacina composição processo para produção de uma preparação imugênica e preparação imugênica | |
| WO2004052930A3 (en) | Targeting single epitopes | |
| EP1502602A3 (en) | Methods for therapeutic vaccination | |
| TR200002611T2 (tr) | Beta-lipotropin ve kullanımları | |
| CY1114127T1 (el) | Χιμαιρικα νουκλεϊνικα οξεα και πολυπεπτιδια του ιου της λυσσας | |
| WO2000018429A3 (en) | Vaccine based on attenuated $i(haemophilus somnus) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B25A | Requested transfer of rights approved |
Owner name: BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) |
|
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/08/2016, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REFERENTE A RPI 2382 DE 30/08/2016, A FIM DE FAZER CONSTAR AS PAGINAS DA LISTAGEM DE SEQUEENCIA. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/04/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 17/04/2020 |